跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,366 条关于
“ELF”
全部
6,366
临床试验
5,630
药物
308
机构
95
资讯
333
10个月前
Galectin Therapeutics' Belapectin Shows Sustained Antifibrotic Effects in MASH Cirrhosis Through 36 Months
10个月前
Chemomab's Nebokitug Shows Sustained Anti-Inflammatory Effects in 48-Week PSC Extension Study
去年
Semaglutide 2.4 mg Shows Promise in MASH Treatment: Phase 3 ESSENCE Trial Results
去年
FDA Authorizes Juul E-Cigarettes for Continued Market Sale After Multiyear Review
去年
Icosabutate Shows Promising Anti-Fibrotic Results in Phase 2b MASH Trial
去年
Chemomab Announces Positive CM-101 Phase 2 Trial Results and Outlines Phase 3 Plans for Primary Sclerosing Cholangitis
去年
Ipsen's Iqirvo (elafibranor) Shows Sustained Efficacy and Safety in Long-Term PBC Treatment
去年
Iqirvo (Elafibranor) Shows Sustained Efficacy and Safety in Long-Term PBC Treatment
去年
Sagimet's Denifanstat Shows Significant Anti-Fibrotic Benefits in Advanced MASH Patients at AASLD 2025
去年
D&D Pharmatech's DD01 Shows Rapid Liver Fat Reduction in MASH Phase 2 Trial, Matching Competitor Results in Quarter of the Time
第 1 页,共 34 页
上一页
下一页